Issue |
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
|
|
---|---|---|
Article Number | 01003 | |
Number of page(s) | 8 | |
Section | Biotechnology and Cell Structure Analysis | |
DOI | https://doi.org/10.1051/bioconf/20235901003 | |
Published online | 08 May 2023 |
Mining natural products related to paclitaxel reveals the possible biosynthetic pathway of paclitaxel
Department of Automation, Tsinghua University, Beijing 10084, People’s Republic of China
Paclitaxel is a widely used anti-tumor drug. Currently, paclitaxel can only be extracted from plants or synthesized by chemical semi-synthesis, which cause environmental damage and cannot meet the growing demand. However, the complete biosynthetic pathway of paclitaxel is still not clear, which greatly limits the production of paclitaxel using methods such as synthetic biology. Here, we deduced the paclitaxel biosynthetic pathway by searching all possible intermediates in the paclitaxel synthesis pathway from the natural product databases. In addition, we performed the transcriptome sequencing of Taxus brevifolia and performed co-expression analysis of the identified genes in the paclitaxel synthesis pathway. All these results laid a solid foundation for the elucidation of paclitaxel biosynthetic pathway.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.